Do We Need Economic Inequality?
The Future of Capitalism 1. Aufl.
Although economic inequality provokes widespread disquiet, its supposed necessity is rarely questioned. At best, a basic level of inequality is seen as a necessary evil. At worst, it is seen as insufficient to encourage aspiration, hard work and investment – a refrain sometimes used to advocate ever greater inequality. In this original new book, Danny Dorling critically analyses historical trends and contemporary assumptions in order to question the idea that inequality is an inevitability. What if, he asks, widespread economic inequality is actually just a passing phase, a feature of the capitalist transition from a settled rural way of life to our next highly urban steady-state? Is it really likely that we face a Blade Runner-style dystopian future divided between a tiny elite and an impoverished mass? Dorling shows how, amongst much else, a stabilizing population, changing gender relations and rising access to education make a more egalitarian alternative to this nightmare vision not only preferable, but realistic. This bold contribution to one of the most significant debates of our time will be essential reading for anyone interested in our economic, social and political destiny.
Contents 1. Bell Curves 2. A history of inequality 3. Why argue for inequality? 4. Who benefits from inequality? 5. Where do the costs of inequality fall? 6. What are the alternatives to inequality? 7. When will the fall in inequality become clear? 8. Reasons for Optimism
"Provocative as always, Danny Dorling challenges us with encyclopaedic knowledge, damning statistics and original insights. Thoughtfully, he helps us to envision a better society and to believe that we might achieve it."Kate Pickett, University of York
Danny Dorling is the Halford Mackinder Professor of Geography at the University of Oxford. His website can be found at www.dannydorling.org.
NeuheitenAb morgen spielen wir Königsklasse 26,99 €
Signal-Switchable Electrochemical S... 124,99 €
Molecular Technology 124,99 €
Early Drug Development 268,99 €
Audit and Accounting Guide 113,99 €